Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes

Radiation and Environmental Biophysics

Volumn 52, Issue 2, 2013, Pages 287-291

  Hedayati, Monireh ^a   Shafaghati, Nayereh ^a   Hosseinimehr, Seyed Jalal ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

131I; Genotoxicity; Micronucleus; Radioiodine; Resveratrol

Indexed keywords

GENETIC DAMAGE; GENOTOXICITIES; HUMAN LYMPHOCYTES; HUMAN VOLUNTEERS; MICRONUCLEUS; NATURAL PRODUCTS; PROTECTIVE EFFECTS; RADIOIODINE;

LYMPHOCYTES;

RESVERATROL;

MUTAGENIC AGENT; RADIOACTIVE IODINE; RADIOPROTECTIVE AGENT; RESVERATROL; STILBENE DERIVATIVE;

ADULT; ARTICLE; CELL CULTURE; HUMAN; LYMPHOCYTE; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; RADIATION EXPOSURE;

ADULT; CELLS, CULTURED; HUMANS; IODINE RADIOISOTOPES; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS; RADIATION-PROTECTIVE AGENTS; STILBENES;

EID: 84883051001     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-013-0461-1     Document Type: Article

References (35)

1. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R (2002) Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat Res 514(1-2):77-85
2. Bisht K, Wagner KH, Bulmer AC (2010) Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 278(1):88-100
3. Csiszar A (2011) Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y Acad Sci 1215:117-122
4. de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75(5):734-739
5. Edmonds CJ, Smith T (1986) The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59(697):45-51
6. Fallahi B, Adabi K, Majidi M, Fard-Esfahani A, Heshmat R, Larijani B, Haghpanah V (2011) Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment. Clin Nucl Med 36(4):277-282
7. Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455(1-2):81-95
8. Fernandez AF, Fraga MF (2011) The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics 6(7):870-874
9. Frombaum M, Le Clanche S, Bonnefont-Rousselot D, Borderie D (2012) Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: potential benefits to cardiovascular diseases. Biochimie 94(2):269-276
10. Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R (1997) Micronuclei induction by 131I exposure: study in hyperthyroidism patients. Mutat Res 373(1):39-45
11. Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R (1999) Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test. Eur J Nucl Med 26(12):1589-1596
12. Hosseinimehr SJ (2009) Potential utility of radioprotective agents in the practice of nuclear medicine. Cancer Biother Radiopharm 24(6):723-731
13. Hosseinimehr SJ (2010) Flavonoids and genomic instability induced by ionizing radiation. Drug Discov Today 15(21-22):907-918
14. Huang X, Zhu HL (2011) Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem 11(5):479-490
15. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117(19):4439-4446
16. Kang HJ, Youn YK, Hong MK, Kim LS (2011) Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals. J Korean Med Sci 26(7):893-899
17. Kim MY (2012) Nitric oxide triggers apoptosis in A375 human melanoma cells treated with capsaicin and resveratrol. Mol Med Report 5(2):585-591
18. Kolade VO, Bosinski TJ, Ruffy EL (2005) Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease. Pharmacotherapy 25(7):1017-1020
19. Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH, Lin CC (2010) Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food 13(6):1415-1423
20. Lin H, Xiong W, Zhang X, Liu B, Zhang W, Zhang Y, Cheng J, Huang H (2011) Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep 26(4):925-930
21. Little JB (2000) Radiation carcinogenesis. Carcinogenesis 21(3):397-404
22. Monteiro Gil O, Oliveira NG, Rodrigues AS, Laires A, Ferreira TC, Limbert E, Leonard A, Gerber G, Rueff J (2000) Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. Mutagenesis 15(1):69-75
23. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S (2005) Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46(2):261-266
24. Robbins RJ, Schlumberger MJ (2005) The evolving role of (131)I for the treatment of differentiated thyroid carcinoma. J Nucl Med 46(Suppl 1):28S-37S
25. Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451-457
26. Schroeder T, Kuendgen A, Kayser S, Kroger N, Braulke F, Platzbecker U, Klarner V, Zohren F, Haase D, Stadler M et al (2012) Therapy-related myeloid neoplasms following treatment with radioiodine. Haematologica 97(2):206-212
27. Sebai H, Hovsepian S, Ristorcelli E, Aouani E, Lombardo D, Fayet G (2010) Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5. Thyroid 20(2):195-203
28. Sebastia N, Montoro A, Montoro A, Almonacid M, Villaescusa JI, Cervera J, Such E, Silla A, Soriano JM (2011) Assessment in vitro of radioprotective efficacy of curcumin and resveratrol. Radiat Meas 46(9):962-966
29. Shi Y, Yang S, Troup S, Lu X, Callaghan S, Park DS, Xing Y, Yang X (2011) Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1. Oncol Rep 25(6):1713-1719
30. Shih A, Davis FB, Lin HY, Davis PJ (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 87(3):1223-1232
31. Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, Jager W (2011) Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci 1215:89-95
32. Truong M, Cook MR, Pinchot SN, Kunnimalaiyaan M, Chen H (2011) Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Ann Surg Oncol 18(5):1506-1511
33. Watanabe N, Kanegane H, Kinuya S, Shuke N, Yokoyama K, Kato H, Tomizawa G, Shimizu M, Funada H, Seto H (2004) The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes. J Nucl Med 45(4):608-611
34. Wood LG, Wark PA, Garg ML (2010) Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 13(10):1535-1548
35. Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J (2011) Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS ONE 6(11):e27081